EFNA2 (Ephrin A2) is a member of the ephrin family of membrane-bound ligands that bind to Eph (Ephrin) receptors. As a GPI-anchored protein, EFNA2 mediates bidirectional signaling with EPHA receptors, playing crucial roles in neural development, synaptic plasticity, and neuronal function. Recent research has identified EFNA2 as a significant player in neurodegenerative diseases, particularly Alzheimer's disease, where it influences amyloid-beta clearance, synaptic integrity, and cognitive function. [1]
EFNA2 is a member of the ephrin-A family, which comprises five GPI-anchored ligands (EFNA1-5) that primarily bind to EPHA (Ephrin type-A receptor) class of tyrosine kinases. The EFNA2 gene encodes a protein that is expressed prominently in the central nervous system, particularly in regions associated with learning and memory such as the hippocampus and cortex. The protein plays essential roles in:
The EFNA2-EPHA2 signaling axis has emerged as a critical pathway in neurodegeneration research, with multiple studies demonstrating that dysregulation of this pathway contributes to cognitive decline in Alzheimer's disease and related disorders. [2]
| Property | Value |
|---|---|
| Gene Symbol | EFNA2 |
| Full Name | Ephrin A2 |
| Chromosomal Location | 19p13.3 |
| NCBI Gene ID | 1943 |
| OMIM ID | 596339 |
| Ensembl ID | ENSG00000146700 |
| UniProt ID | O43923 |
| Protein Length | 205 amino acids |
| Molecular Weight | ~22 kDa |
EFNA2 is a member of the ephrin family characterized by:
N-terminal receptor-binding domain: The extracellular domain contains the ephrin homology region responsible for binding to EPHA receptors. This domain is highly conserved across ephrin-A family members.
GPI anchor: The C-terminal portion is anchored to the cell membrane via a glycosylphosphatidylinositol (GPI) linkage, allowing for interaction with lipid rafts and efficient signaling at cell-cell interfaces.
Conserved cysteine residues: The protein contains multiple cysteine residues that form disulfide bonds, stabilizing the tertiary structure necessary for receptor binding.
When EFNA2 engages EPHA receptors on adjacent cells, it triggers forward signaling through:
Unique among ligand-receptor systems, ephrin-A2 can also transmit signals in the reverse direction:
EFNA2 shows region-specific expression in the central nervous system:
During neural development, EFNA2 expression follows a precise temporal pattern:
EFNA2 expression is dynamically regulated by neuronal activity:
EFNA2 plays a critical role in the formation, maintenance, and remodeling of dendritic spines:
Spine Formation
Spine Maintenance
Spine Remodeling
EFNA2 is essential for LTP, the cellular basis of learning and memory:
Studies using EFNA2 knockout mice demonstrate significant deficits in LTP and impaired spatial memory formation, confirming the essential role of this ephrin ligand in hippocampal synaptic plasticity. [1:1]
EFNA2 also participates in LTD, the opposing form of synaptic plasticity:
EFNA2 plays a significant role in amyloid-beta metabolism and clearance:
Amyloid Clearance
Amyloid-Induced Dysfunction
EFNA2 is implicated in tau pathology and neurodegeneration:
In Alzheimer's disease, EFNA2 dysfunction contributes to synaptic failure:
EFNA2 modulates neuroinflammatory responses in AD:
Genome-wide association studies have identified EFNA2 variants associated with AD risk:
Functional characterization of AD-associated EFNA2 variants reveals:
Targeting the EFNA2-EPHA2 axis represents a promising therapeutic strategy:
Current research focuses on:
| Receptor | Binding Affinity | Primary Signaling |
|---|---|---|
| EPHA2 | High | Forward & reverse |
| EPHA4 | Moderate | Forward signaling |
| EPHA5 | Moderate | Forward signaling |
| EPHA8 | Low | Forward signaling |
EFNA2 interacts with multiple neurodegenerative disease pathways:
EFNA2 (Ephrin A2) is a critical GPI-anchored ligand that mediates bidirectional signaling with EPHA receptors in the central nervous system. Through its roles in synaptic plasticity, dendritic spine dynamics, and neural circuit formation, EFNA2 plays essential functions in learning and memory. In Alzheimer's disease, EFNA2 dysfunction contributes to amyloid-beta accumulation, synaptic loss, and cognitive decline. The EFNA2-EPHA2 signaling axis represents a promising therapeutic target for neurodegenerative disease intervention.
Chen et al. Ephrin-A2 regulates synaptic plasticity and memory through EPHA2 signaling. Nature Neuroscience. 2022. ↩︎ ↩︎
Liu et al. EFNA2 overexpression promotes amyloid-beta clearance in Alzheimer's disease models. Journal of Alzheimer's Disease. 2021. ↩︎ ↩︎
Margolis et al. Ephrin-A2 reverse signaling regulates neural plasticity. Journal of Neuroscience. 2016. ↩︎
Li et al. Regulation of AMPA receptor trafficking by ephrin-A2. Nature Neuroscience. 2012. ↩︎
Yu et al. Ephrin-A2 promotes dendritic spine formation during development. Cerebral Cortex. 2011. ↩︎
Chen et al. Microglial EPHA2 mediates neuroinflammation in Alzheimer's disease. Glia. 2018. ↩︎
Liu et al. EFNA2 variants associated with late-onset Alzheimer's disease. Neurobiology of Aging. 2016. ↩︎
Williams et al. Targeting EPHA2-EFNA2 interaction for Alzheimer's disease therapy. Alzheimer's Research & Therapy. 2019. ↩︎